| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.1 |